Expanded Access for Mezigdomide
NCT06994117 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2025-12-11
Summary
This is an expanded access designed to provide access to Mezigdomide for eligible participants.
Interventions
- DRUG
-
Mezigdomide
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
NCT00001081 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
NCT00002191 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
NCT01933594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
NCT00002067 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
NCT00000994 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis
NCT00659971 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
Triage Survey for Infectious Disease Eligibility
NCT06492187 ·Status: RECRUITING
-
Safety and Tolerability of Z-100 in Patients With Early HIV Infection
NCT00016692 ·Status: TERMINATED ·Phase: PHASE1
-
Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
NCT00002035 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002
NCT00000682 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition
NCT00002300 ·Status: COMPLETED ·Phase: PHASE2
-
Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects
NCT00352911 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
NCT00000737 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E
NCT00002094 ·Status: COMPLETED ·Phase: NA
-
Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels
NCT00143624 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
NCT00004986 ·Status: TERMINATED ·Phase: PHASE3
-
An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola
NCT04268966 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides
NCT00002114 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
NCT00000671 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
NCT00000625 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002097 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
NCT00000736 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks
NCT00000670 ·Status: COMPLETED ·Phase: NA
-
A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
NCT00000993 ·Status: COMPLETED ·Phase: NA